Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.
Riding an endless wave of nostalgia, one company is exhuming the intellectual property of midcentury designers to create new ...
The Company had previously announced that it was notified by Nasdaq on December 4, 2025, that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550 (a) ...
This article explores three critical fronts shaping the future of IP: federal AI legislation and executive preemption, ...
Despite fears of a possible bubble bursting, artificial intelligence (AI) is a technology that increasingly looks like it's not going away. There are already businesses winning the AI race, whether ...
As the Story ecosystem expands across AI, media, data and real-world IP, initiatives like Poseidon provide tangible validation of the network’s role in enabling compliant, monetizable IP at scale, ...
Throughout 2025, Clearmind achieved critical milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100, a proprietary non-hallucinogenic MEAI-based oral compound designed to address AUD—a ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Have you ever questioned how ChatGPT or any other AI you use to ask questions or do research gets all its information? Well, ...
Giving glove materials a verifiable “memory” to support safe recovery, traceability, and circular reuse NEW YORK, NY / ACCESS Newswire / December 31, 2025 / SMX (Security Matters) PLC (NASDAQ:SMX; ...
Disney preempted the announcement of this deal by delivering a cease-and-desist letter to Google (GOOG) on Wednesday evening. The letter accuses Google (and Google's Gemini AI) of widespread copyright ...
Giving Materials Memory” enables denim to be authenticated, traced & reintroduced as a higher-value, verifiable input for reuse and recycling NEW YORK CITY, NEW YORK / ACCESS Newswire / December 30, ...